# DEXAMETHASONE SODIUM PHOSPHATE
> **ANDA214890** · Abbreviated New Drug Application (Generic) · Sponsor: GENEYORK PHARMS · Approved 2023-07-07
## Drug
- **FDA Application Number:** ANDA214890
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXAMETHASONE SODIUM PHOSPHATE
- **Generic name:** Dexamethasone Sodium Phosphate
- **Active ingredients:** DEXAMETHASONE SODIUM PHOSPHATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** GENEYORK PHARMS
- **First approval:** 2023-07-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214890)
---
*AI Analytics · CC0 1.0*